Microbiological Testing/Measurement TRIZ Cases

Specific serum microRNAs distinguish rapid from slow Parkinson's progression, enabling more objective prognosis and treatment selection.

Circular chimeric constructs with probe ligation and rolling circle amplification improve blood-based detection of rare mutations and methylation changes.

Rapid TR-LAMP detects TR34 tandem repeats in Aspergillus with high specificity under isothermal conditions, avoiding PCR lab equipment.

DNA-origami chiral plasmonic constructs turn analyte binding into visible color changes, enabling reliable sensing without CD spectrometry.

Droplet digital PCR with MS and REF probes detects microsatellite instability in low-concentration DNA with 0.1% sensitivity.

Acidic pH and chaotropic salts bind sulfonated DNA to silica, reducing sample loss and improving bisulfite recovery for methylation detection.

Ratio imaging of paired biomarkers cancels thickness-related optical artifacts and improves DCIS aggressiveness stratification.

Microparticles capture and concentrate analytes before paper-spray ionization, reducing matrix interference in serum, plasma, and urine.

Hairpin barcode primers shield UMIs during PCR to cut non-specific products, improve library purity, and boost rare variant detection.

Tiled short probes and higher annealing temperatures raise small-panel capture efficiency and on-target rate while simplifying automation.

Different detection temperatures let multiple nucleic acid sequences be identified in one vessel with one label, avoiding melting analysis and saving time.

Sequence-specific DNA cleavage enables large genomic deletions while reintroducing essential genes to preserve cell survival and support genome analysis.

Target-dependent capture oligomers control nucleic acid input for sequencing, avoiding support saturation, dimers, and poor library quality.

Droplet barcoding profiles single-cell chromatin states with higher locus recovery and lower bias to identify drug-resistant cell populations.

Sequential hybridization builds pseudo-color barcodes with error correction, reducing imaging noise while scaling in situ RNA detection.

Copy-number segment patterns across chromosome arms simplify HRD detection, improving accuracy while reducing computational complexity.

Molecular barcodes and nanopore sequencing screen multiple enzyme variants in parallel, improving kinetics measurement speed and accuracy.

Preloaded cartridges and random-access test stations cut infection ID and antimicrobial susceptibility testing from days to hours.

Degenerate PCR primers and phylogenetic analysis expand HPV screening to 65 genotypes, reducing miss-detection of medium- and high-risk strains.

Gene-expression subgrouping is paired with prognostic comparison to identify target proteins and companion biomarkers for treatment response.

Blood-based GULP1 detection improves early liver cancer diagnosis and recurrence prediction while avoiding biopsy bleeding risk.

A selector set targeting recurrent mutations enriches cell-free DNA, enabling sensitive blood-based tumor monitoring without patient-specific assays.

A reference fluorescence area corrects spot intensity variation, improving nucleic acid sequence detection accuracy and reducing false results.

Dual-target real-time PCR uses conserved EBV regions and specific probes to improve sensitive, reproducible detection and quantitation.

A paper sensor separates bead-bound PCR amplicons by filtration and capillary flow for accurate visual nucleic acid detection at POCT.

A multi-gene PSC marker panel improves detection of rare residual pluripotent stem cells and supports safer cell therapy quality control.

Alkaline pretreatment and enzymatic hydrolysis improve low-level beta-glucan measurement in corn biomass for biofuel and brewing.

Magnetic-bead DNA isolation and bisulfite pre-amplification improve recovery and multiplex detection of low-copy plasma DNA with fewer false negatives.

Cleavable labels and pre-amplifier cascades raise RNA ISH multiplexing while preserving sensitivity, morphology, and workflow efficiency.

Automated synonym-based sequence retrieval expands variant coverage and improves oligonucleotide specificity while reducing manual design time.

Uracil-guided digestion and ligation convert linear dsDNA into covalently closed vectors that resist exonuclease degradation and extend gene expression.

A cleavable segregating probe protects target-bound rare sequences, enabling selective capture and release from excess wild-type DNA.

High-salt, low-nucleotide complex assembly boosts polymerase processivity, improving nanopore sequencing yield and read length.

Selective chemical modification blocks DNA from non-viable cells, enabling consistent viability PCR without light-dependent photoactivation.

Ribonuclease and single-strand nuclease fragment RNA:DNA hybrids to preserve strand specificity, reduce bias, and speed RNA-seq library prep.

Customized nucleic acid probes target patient-specific variants, cutting exome-scale sequencing cost while preserving clinically useful detection.

Genomic DLBCL classification separates five molecular classes to match targeted therapies for recurrent or progressive disease.

Separating linker-DNA nucleosomes from blood enriches tumor-derived fragments, reducing non-tumor interference and improving ctDNA test sensitivity.

Molecular Index Tags separate amplification and base-calling errors from real variants while limiting tag length, cost, and read loss.

Magnetically responsive sensors detect nucleotide-linked particles through resistance changes, simplifying bulky and costly SBS sequencing.

Whole-blood gene expression clustering reveals reproducible sepsis phenotypes that better match patients to targeted interventions.

Parental genotype data reconstructs noisy fetal or embryo DNA, correcting allele drop-out and improving aneuploidy detection.

Sequential membrane coupling and uncoupling enables nanopore detection of multiple analytes at ultra-low concentration without signal interference.

Tailored neoantigen peptides improve MHC binding to boost tumor-specific T cell responses while limiting normal tissue damage.

Multi-biomarker profiling of DCIS lesions improves recurrence and invasive cancer risk assessment to support more tailored treatment decisions.

Reconstructed patient and database haplotypes let NGS workflows match differently represented variants efficiently across sequencing platforms.

Measuring TGFbeta pathway activity in cancer samples helps identify likely immunotherapy responders early and avoid ineffective treatment delays.

Detecting cardiolipin isoforms and TAZ1, MLCL AT1, or ALCAT1 markers improves heart failure diagnosis and treatment monitoring.

Targeted CAN-gene mutation panels improve breast and colorectal cancer diagnosis and therapy stratification without full genome analysis.

Sequence-based machine learning links recombinant payload features to host-cell toxicity before scale-up, helping preserve viral titer and safer expression.